Grant: Master's Award: Canada Graduate Scholarships
McGill University
$17,500.00
MicroRNA profiles of ovarian cancer metastasis and treatment resistance
EF 2016-17
Résumé
Ovarian cancer remains the most lethal gynecologic malignancy in industrialized countries despite advances in detection and therapies. Early dissemination (metastasis), and treatment-resistance represent major clinical challenges. MicroRNAs (miRNAs), a class of small noncoding RNAs, exert a widespread control over gene regulation, and are also involved in a great variety of human cancers. Their expression patterns can be advantageously used to determine tumour origin and to anticipate responses to treatment. Aim 1. Ascites, a malignant fluid accumulation in the patient abdominal cavity, is frequently associated with ovarian metastatic cancer. We will use miRNA profiles to investigate whether ascites-derived tumour cells are originated from primary or metastatic tumours, and whether they represent a transitional state between early and disseminated cancer. Aim 2. PARPi recently became available for targeted therapy of ovarian cancer. Patient responses vary depending on cellular proficiency in the DNA double strand break repair pathway, wherein the BRCA1 gene plays a key role. MiRNA profiles will be compared in PARPi sensitive and resistant cells, and in BRCA1-deficient and proficient cells. With this aim, we hope to refine treatment-sensitive and resistant ovarian cancer subtypes.This project will further the current knowledge on ovarian cancer, and provide new tools to better educate prognosis and treatment of the disease.
Programme
Master's Award: Canada Graduate Scholarships
Bénéficiaire
Emplacement
Quebec, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
367352
Name
Tseng Hsin Wei
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
MicroRNA profiles of ovarian cancer metastasis and treatment resistance
Programtype2
Studentship Programs
Orgnameinp2
McGill University
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Ascites; Brca1; Metastasis; Mirna; Ovarian Cancer; Parp Inhibitor
Abstract
Ovarian cancer remains the most lethal gynecologic malignancy in industrialized countries despite advances in detection and therapies. Early dissemination (metastasis), and treatment-resistance represent major clinical challenges. MicroRNAs (miRNAs), a class of small noncoding RNAs, exert a widespread control over gene regulation, and are also involved in a great variety of human cancers. Their expression patterns can be advantageously used to determine tumour origin and to anticipate responses to treatment. Aim 1. Ascites, a malignant fluid accumulation in the patient abdominal cavity, is frequently associated with ovarian metastatic cancer. We will use miRNA profiles to investigate whether ascites-derived tumour cells are originated from primary or metastatic tumours, and whether they represent a transitional state between early and disseminated cancer. Aim 2. PARPi recently became available for targeted therapy of ovarian cancer. Patient responses vary depending on cellular proficiency in the DNA double strand break repair pathway, wherein the BRCA1 gene plays a key role. MiRNA profiles will be compared in PARPi sensitive and resistant cells, and in BRCA1-deficient and proficient cells. With this aim, we hope to refine treatment-sensitive and resistant ovarian cancer subtypes.This project will further the current knowledge on ovarian cancer, and provide new tools to better educate prognosis and treatment of the disease.
Competitiondate
201612
Approvedterm2
1 yr 0 mth
Pinamesdelim
Tseng, Hsin Wei
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~